Skip to main content
SpringerLink
Log in

Adalimumab

Papillary thyroid carcinoma

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Uslu S. PAPILLARY THYROID CARCINOMA FOLLOWING ADALIMUMAB TREATMENT IN ANKYLOSING SPONDYLITIS: A CAUSAL OR COINCIDENTAL ASSOCIATION?. Acta endocrinologica (Bucharest, Romania) 19 : 376-379, No. 3, Sep 2023. Available from: URL: https://dx.doi.org/10.4183/aeb.2023.376

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 2002, 20 (2024). https://doi.org/10.1007/s40278-024-55397-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-55397-9

Search

Navigation